After many decades of effort, the future of gene and cell therapies is incredibly promising. While these technologies were initially developed in the context of treating rare diseases caused by a single faulty gene, a variety of gene and cell-based therapies for both rare and common diseases are currently in development. In addition, dedicated resources, facilities and expertise are evolving to scale up and work towards the clinical development and the commercial production.
This conference will bring together experts in this space.

We are close to huge breakthroughs in a new field of medicine that would create a new paradigm for healthcare.

Since 2009, each year the BioRN Annual Conference has been a valuable source of top information, lively discussions and networking opportunities with international experts from different fields of the life sciences.